AHA Reexamines Benefits of Vytorin

November 18, 2014 4:31 PM

13 0

AHA Reexamines Benefits of Vytorin

Several years ago, cardiologist passed over the cholesterol treatment called Vytorin, calling it nothing more than an expensive placebo, but after new research this week, the cholesterol-lowering medication might be on its way back up and into the market.

Researchers from the American Heart Association met on Monday and presented new data from a completely randomized double-blind study involving at least 18,000 patients at high risk for cholesterol issues. They found that those patients taking Vytorin—which is actually a drug that combines the benefi...

Read more

To category page